课题基金 / 基金详情

NOVAL HUMAN MACROPHAGE RECEPTOR

NOVAL HUMAN MACROPHAGE RECEPTOR
新型人类巨噬细胞受体
批准号:
6290585
负责人:
JUAN M SAAVEDRA
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

JUAN M SAAVEDRA的其他基金

相关文献

中文摘要
翻译
我们正在继续努力从人类单核细胞和大鼠脾脏获得的cDNA文库中克隆新的巨噬细胞受体。我们使用选择性碘化配体的定量放射自显影技术发现,这种新型巨噬细胞受体只有在脑损伤导致细胞死亡后才会在大鼠大脑中表达,比如下橄榄的化学损伤。在该模型中,受体的表达与脑损伤程度和损伤神经元数量成正比。这些观察结果表明,测定这种新型巨噬细胞受体的表达可以作为一种定量方法来估计脑损伤和神经元死亡的程度。-人巨噬细胞/克隆/免疫学/脑损伤
英文摘要
We are continuing our efforts to clone the novel macrophage receptor form cDNA libraries obtained from human monocytes and from rat spleen. We have found, using quantitative autoradiography with selective iodinated ligands, that the novel macrophage receptor is expressed in the rat brain only after brain lesions resulting in cell death, such as chemical lesions of the inferior olive. The receptor expression is proportional to the degree of brain injury and to the number of injured neurons in this model. These observations indicate that determination of the expression of the novel macrophage receptor may be used as a quantitative method to estimate the degree of brain damage and neuronal death. - human macrophages/cloning/immunology/brain injury
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Brain pathophysiology in SARS-CoV-2 disease
  • 批准号:
    10317394
  • 项目类别:
  • 资助金额:
    $66.15万
  • 财政年份:
    2021
  • 负责人:
    JUAN M SAAVEDRA
  • 依托单位:
Brain pathophysiology in SARS-CoV-2 disease
  • 批准号:
    10617754
  • 项目类别:
  • 资助金额:
    $62.36万
  • 财政年份:
    2021
  • 负责人:
    JUAN M SAAVEDRA
  • 依托单位:
Brain pathophysiology in SARS-CoV-2 disease
  • 批准号:
    10434951
  • 项目类别:
  • 资助金额:
    $63.05万
  • 财政年份:
    2021
  • 负责人:
    JUAN M SAAVEDRA
  • 依托单位:
Mechanistic studies on stress, brain inflammation and neuroprotection